TCM
Tang Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.9M | Sell |
1,236,027
-1,080
| -0.1% | -$55K | 3.18% | 6 |
|
|
2025
Q1 | $55.7M | Hold |
1,237,107
| – | – | 3.08% | 8 |
|
|
2024
Q4 | $51.2M | Sell |
1,237,107
-50,000
| -4% | -$2.07M | 3.38% | 5 |
|
|
2024
Q3 | $50.2M | Hold |
1,287,107
| – | – | 3.59% | 5 |
|
|
2024
Q2 | $44M | Buy |
1,287,107
+100,000
| +8% | +$3.42M | 4.48% | 4 |
|
|
2024
Q1 | $29.8M | Buy |
1,187,107
+50,000
| +4% | +$1.26M | 3.1% | 5 |
|
|
2023
Q4 | $33.6M | Hold |
1,137,107
| – | – | 3.1% | 7 |
|
|
2023
Q3 | $35.9M | Hold |
1,137,107
| – | – | 5.07% | 2 |
|
|
2023
Q2 | $29.4M | Sell |
1,137,107
-32,893
| -3% | -$851K | 4.33% | 3 |
|
|
2023
Q1 | $28.1M | Buy |
1,170,000
+50,000
| +4% | +$1.2M | 4.19% | 3 |
|
|
2022
Q4 | $21.8M | Buy |
1,120,000
+670,000
| +149% | +$13.1M | 3.17% | 9 |
|
|
2022
Q3 | $9.46M | Buy |
450,000
+350,000
| +350% | +$7.35M | 1.16% | 25 |
|
|
2022
Q2 | $1.95M | Buy |
+100,000
| New | +$1.95M | 0.3% | 50 |
|